Driessen, J. H. M., Henry, R. M. A., van Onzenoort, H. A. W., Lalmohamed, A., Burden, A. M., Prieto-Alhambra, D., . . . de Vries, F. (2015). Bone Fracture Risk is Not Associated with the Use of Glucagon-Like Peptide-1 Receptor Agonists: A Population-Based Cohort Analysis. Calcif Tissue Int.
Chicago Style citaatDriessen, Johanna H. M., Ronald M. A. Henry, Hein A. W. van Onzenoort, Arief Lalmohamed, Andrea M. Burden, Daniel Prieto-Alhambra, Cees Neef, Hubert G. M. Leufkens, en Frank de Vries. "Bone Fracture Risk Is Not Associated With the Use of Glucagon-Like Peptide-1 Receptor Agonists: A Population-Based Cohort Analysis." Calcif Tissue Int 2015.
MLA citatieDriessen, Johanna H. M., et al. "Bone Fracture Risk Is Not Associated With the Use of Glucagon-Like Peptide-1 Receptor Agonists: A Population-Based Cohort Analysis." Calcif Tissue Int 2015.